Thalidomide has become a novel agent in the treatment of multiple myeloma and many other hematological and solid malignancies. Thalidomide has various adverse effects including neurologic, hematologic, cardiovascular, gastrointestinal, and endocrinologic toxicities. However, with strict regulations for use, there have been few case reports of thalidomide toxicity. A 42-year-old man presented with both breast engorgement and tenderness for 1 year. Six years ago, he had been diagnosed malignant histiocytosis at left palpable axillary mass lesion. He was treated with chemotherapy according to Langerhans cell histiocytosis. But, 6 months later, the response of chemotherapy was refractory and then, he has been received thalidomide salvage therapy (25-100 ㎎/day) for 5 years. Mammography and ultrasonography revealed a bilateral heterogeneous mixed echoic lesion suggesting a fibroglandular tissue under the nipple and subcutaneous layer. We have treated him with bromocriptine. With a follow-up of 15 months, gynecomastia and breast discomforts were improved.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.